2m 2m 2m 2m 2m 2m 2m
BioAdaptives (BDPT)
OTC
$0.006-$0.002 (-25.00%)
Price as of Jun 03, 2026- $105,916.00Market Cap
- -90.16%1-Year Change
- Packaged FoodsIndustry
BioAdaptives (BDPT)
$0.006-$0.002 (-25.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 18,278 +44.27% | 12,669 -55.65% | 28,565 +66.31% | 17,176 -13.15% | |
Cost of Revenue | 5,781 -33.08% | 8,639 -51.32% | 17,746 +76.58% | 10,050 +3.92% | |
Gross Profit | 12,497 +210.10% | 4,030 -62.75% | 10,819 +51.82% | 7,126 -29.48% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 0 -100.00% | 19,941 -29.22% | 28,174 -54.67% | 62,148 -53.55% | |
Total Operating Expenses | 1.1M +74.00% | 606,120 +152.82% | 239,740 -44.12% | 429,026 -33.61% | |
Operating Profit | -1.0M +73.09% | -602,090 +163.01% | -228,921 -74.44% | -895,570 -14.70% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -70,880 -22.94% | -91,978 -43.53% | -162,891 -43.66% | -289,121 +6.14% | |
Interest Income and Expense and Net | -70,880 -22.94% | -91,978 -43.53% | -162,891 -43.66% | -289,121 +6.14% | |
Total Nonoperating Income and Expense | -515,725 +73.60% | -297,071 -38.56% | -483,545 +2.08% | -473,670 -273.89% | |
Income before Taxes | -1.6M +72.19% | -904,761 +26.99% | -712,466 -20.45% | -895,570 -14.70% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -1.6M +73.26% | -899,161 +26.20% | -712,466 -20.45% | -895,570 -14.70% | |
Net Income from Continuing Operations Applicable to Common | -1.6M +72.19% | -904,761 +26.99% | -712,466 -20.45% | -895,570 -14.70% | |
Basic EPS and Net Income | N/A N/A | -0.11 N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | -0.15 +36.36% | -0.11 N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 10.1M +22.61% | 8.2M -98.53% | 559.1M +427.37% | 106.0M N/A | |
Diluted Weighted Average Shares | 10.1M +22.61% | 8.2M -98.53% | 559.1M N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 158,445 +15.26% | 137,470 +126.19% | 60,776 +139.23% | 25,405 -69.37% | |
Short-Term Investments | 0 N/A | 0 N/A | 0 -100.00% | 42 -77.89% | |
Cash and Cash Equivalents and Short-Term Investments | 158,445 +15.26% | 137,470 +126.19% | 60,776 +138.83% | 25,447 -69.39% | |
Total Current Assets | 211,901 -19.09% | 261,885 +195.72% | 88,557 +158.00% | 34,324 -61.38% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Assets | 225,901 -13.74% | 261,885 +151.82% | 103,998 +178.71% | 37,314 -74.89% | |
Income Taxes Payable | N/A N/A | 0 N/A | 0 N/A | N/A N/A | |
Total Short-Term Debt | 352,332 +13.29% | 311,000 -3.31% | 321,658 -17.95% | 392,039 -10.25% | |
Total Current Liabilities | 2.4M +36.51% | 1.7M -1.42% | 1.8M +17.59% | 1.5M +19.91% | |
Total Long-Term Debt | 32,096 0.00% | 32,096 -90.02% | 321,658 -17.57% | 390,237 -3.20% | |
Total Long-Term Liabilities | 1.7M N/A | N/A N/A | 977,872 N/A | N/A N/A | |
Total Liabilities | 2.4M +36.51% | 1.7M -1.42% | 1.8M +17.59% | 1.5M +19.91% | |
Retained Earnings | -10.7M +17.00% | -9.2M +10.88% | -8.3M +9.43% | -7.6M +13.45% | |
Total Stockholders Equity | -2.1M +45.50% | -1.5M -11.10% | -1.6M +13.44% | -1.5M +32.79% | |
Total Shares Outstanding | 12.0M +46.17% | 8.2M -99.08% | 895.8M +254.68% | 252.6M +397.06% | |
Cash Flow | |||||
Cash from Operating Activities | -516,025 +106.81% | -249,517 +11.50% | -223,773 -1.53% | -227,259 +43.24% | |
Capital Expenditures | 18,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -18,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 555,000 +70.14% | 326,211 +25.88% | 259,144 +52.68% | 169,728 -28.38% | |
Financials Ratio | |||||
Gross Margin | 68.37% +114.94% | 31.81% -16.01% | 37.88% -8.71% | 41.49% -18.81% | |
Operating Margin | -5,701.79% +19.98% | -4,752.47% +493.02% | -801.40% -84.63% | -5,214.08% -1.79% | |
Return on Assets | -638.76% +29.96% | -491.50% -51.26% | -1,008.36% +4.66% | -963.50% -23.18% | |
Return on Equity | 86.70% +49.96% | 57.81% +25.70% | 45.99% -34.66% | 70.39% -17.14% | |
Revenue Growth | 44.27% +179.56% | -55.65% -183.92% | 66.31% +604.35% | -13.15% -162.24% | |
Current Ratio | 0.09 -40.74% | 0.15 +199.80% | 0.05 +119.05% | 0.02 -67.74% | |
Cash Ratio | 0.07 -15.56% | 0.08 +129.68% | 0.03 +102.92% | 0.02 -74.40% | |
Debt-to-Equity Ratio | -0.18 -22.99% | -0.23 -40.01% | -0.39 -27.50% | -0.54 -29.88% | |
Debt-to-Assets Ratio | 1.70 +29.90% | 1.31 -78.82% | 6.19 -70.49% | 20.96 +270.86% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow